Dyachenko P, Monselise A, Shustak A, Ziv M, Rozenman D
Department of Dermatology, Ha'emek Medical Centre, Afula 18101, Israel.
J Eur Acad Dermatol Venereol. 2007 Mar;21(3):340-4. doi: 10.1111/j.1468-3083.2006.01925.x.
Few controlled studies have compared nail disorders in patients with chronic renal failure (CRF) and haemodialysis (HD)-dependent individuals with a healthy population.
The aim of this study was to compare the prevalence of nail disorders in patients with CRF and patients undergoing HD treatment with a healthy population, and evaluate the relationship between nail changes and various demographic, medical and laboratory parameters in these groups.
In this case-control study we recruited 73 patients affected with CRF, 77 patients undergoing regular HD and 77 healthy individuals. All patients were examined for the presence of nail disorders. Various parameters [age, gender, type of kidney disease, regular medications, duration of renal failure and HD, dialysis efficacy (Kt/v), haemoglobin, neutrophil count, calcium, phosphorus, albumin, creatinine, urea, alkaline phosphatase and parathyroid hormone (PTH) levels] of the patients were determined by multivariate analysis and compared.
Forty-four patients (60.3%) with CRF and 48 patients (62.3%) undergoing HD treatment had at least one type of nail pathology. The most common nail alterations found in patients with CRF and those undergoing HD were absence of lunula (AL) and half-and-half nails (HHN), respectively. Prevalence of nail disorders among patients with CRF was influenced significantly by PTH level (P = 0.03). In the HD group, male sex, age above 65 years and comorbidities (diabetes mellitus, hypertension and heart failure) were significantly associated with nail pathologies.
Patients with CRF and those undergoing HD therapy have higher rates of nail disorders when compared to a healthy population. Efficient HD does not improve nail changes.
很少有对照研究比较慢性肾衰竭(CRF)患者、依赖血液透析(HD)的个体与健康人群的指甲疾病情况。
本研究旨在比较CRF患者、接受HD治疗的患者与健康人群中指甲疾病的患病率,并评估这些人群中指甲变化与各种人口统计学、医学和实验室参数之间的关系。
在这项病例对照研究中,我们招募了73例CRF患者、77例接受常规HD治疗的患者和77名健康个体。对所有患者进行指甲疾病检查。通过多变量分析确定并比较患者的各种参数[年龄、性别、肾脏疾病类型、常规用药、肾衰竭和HD的持续时间、透析效能(Kt/v)、血红蛋白、中性粒细胞计数、钙、磷、白蛋白、肌酐、尿素、碱性磷酸酶和甲状旁腺激素(PTH)水平]。
44例(60.3%)CRF患者和48例(62.3%)接受HD治疗的患者至少有一种指甲病变。在CRF患者和接受HD治疗的患者中发现的最常见的指甲改变分别是甲半月缺失(AL)和对半甲(HHN)。CRF患者中指甲疾病的患病率受PTH水平的显著影响(P = 0.03)。在HD组中,男性、65岁以上年龄和合并症(糖尿病、高血压和心力衰竭)与指甲病变显著相关。
与健康人群相比,CRF患者和接受HD治疗的患者指甲疾病的发生率更高。有效的HD并不能改善指甲变化。